Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.75
Bid: 21.50
Ask: 22.00
Change: -1.75 (-7.45%)
Spread: 0.50 (2.326%)
Open: 24.25
High: 25.00
Low: 21.75
Prev. Close: 23.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: JPMorgan ups Rio Tinto; Redburn likes Carnival

Thu, 14th Sep 2023 09:22

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

JPMorgan raises Anglo American price target to 2,900 (2,650) pence - 'overweight'

----------

JPMorgan raises Rio Tinto to 'neutral' (underweight) - price target 6,000 (5,440) pence

----------

Berenberg raises B&M European Value Retail price target to 645 (640) pence - 'buy'

----------

Investec raises Associated British Foods to 'add' (hold) - price target 2,195 (1,912) pence

----------

Bernstein raises Associated British Foods price target to 2,800 (2,600) pence - 'outperform'

----------

FTSE 250

----------

Berenberg raises Greggs price target to 3,440 (3,200) pence - 'buy'

----------

Berenberg cuts Energean price target to 1,555 (1,570) pence - 'buy'

----------

Berenberg raises Direct Line Insurance price target to 161 (152) pence - 'hold'

----------

JPMorgan raises Trainline price target to 295 (280) pence - 'neutral'

----------

UBS raises Redrow price target to 585 (565) pence - 'buy'

----------

Redburn Atlantic raises Carnival to 'buy' from 'neutral' - target price USD23

----------

SMALL CAP

----------

Jefferies raises THG price target to 105 (95) pence - 'buy'

----------

Berenberg raises Burford Capital price target to 1,600 (1,350) pence - 'buy'

----------

Berenberg cuts DFS Furniture price target to 155 (195) pence - 'buy'

----------

JPMorgan raises BHP Group price target to 2,550 (2,320) pence - 'neutral'

----------

Jefferies raises Angle price target to 75 (65) pence - 'buy'

----------

Jefferies cuts Frontier Developments price target to 520 (680) pence - 'buy'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
14 Aug 2020 12:41

Angle's Parsortix Able To Predict Patients' Response To Treatment

Angle's Parsortix Able To Predict Patients' Response To Treatment

Read more
20 Jul 2020 20:03

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

Read more
20 Jul 2020 10:16

Angle's 'Parsortix' advantageous in breast cancer in new research

(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.

Read more
25 Jun 2020 12:22

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

Read more
18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Jun 2020 16:41

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

Read more
12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Read more
12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

Read more
31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Read more
31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

Read more
3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

Angle Parsortix Test Used To Help Discover Brain Metastasis

Read more
27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Read more
27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.